Curaleaf Holdings, Inc. Canadian Securities Exchange

CURA

CA23126M1023

Pharmaceuticals

End-of-day quote Canadian Securities Exchange Other stock markets			5-day change	1st Jan Change
- ^CAD	-.--%		-10.77%	-10.46%

Apr. 05	Curaleaf Is Exploring Secondary Listing In Europe, Including Frankfurt And London - FT	RE
Mar. 19	Curaleaf Holdings Agrees to Buy Northern Green Canada to Bolster European Flower Supply	MT

Curaleaf Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022

May 10, 2022 at 05:33 pm EDT

Curaleaf Holdings, Inc. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported revenue was USD 313.07 million compared to USD 260.32 million a year ago. Net loss was USD 19.99 million compared to USD 14.82 million a year ago. Basic loss per share from continuing operations was USD 0.03 compared to USD 0.02 a year ago.

Latest news about Curaleaf Holdings, Inc.

Curaleaf Is Exploring Secondary Listing In Europe, Including Frankfurt And London - FT	Apr. 05	RE
Curaleaf Holdings Agrees to Buy Northern Green Canada to Bolster European Flower Supply	Mar. 19	MT
Curaleaf Brief: Buying Northern Green Canada to Bolster European Flower Supply	Mar. 19	MT
Curaleaf Holdings, Inc. signed a deal to acquire Northern Green Canada Inc..	Mar. 18	CI
Curaleaf Holdings, Inc. agreed to acquire Northern Green Canada Inc.	Mar. 18	CI
Cannabis Stocks Gain Following Rumors of Imminent Rescheduling	Mar. 15	DJ
Curaleaf Expanding into Czech Republic with Astrasana Pharma Partnershi	Mar. 14	MT
Curaleaf Brief: Expanding into Czech Republic with Astrasana Pharma Partnership	Mar. 14	MT
Cannabis Stocks Retreat After WSJ Report of DEA Concerns	Mar. 11	DJ
Cannabis Shares Gain After Biden Says Marijuana Laws Should Be Loosened	Mar. 08	DJ
Curaleaf Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 06	CI
Transcript : Curaleaf Holdings, Inc., Q4 2023 Earnings Call, Mar 06, 2024	Mar. 06
Curaleaf Reports Q4 2023 Adjusted Loss of US$5 Million	Mar. 06	MT
Curaleaf Brief: Fourth quarter 2023 revenue of US$345 million, representing an increase of 4% quarter-over-quarter	Mar. 06	MT
North American Morning Briefing : Stock Futures Rise Ahead of Powell's Testimony	Mar. 06	DJ
Curaleaf Holdings, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Mar. 05	CI
Curaleaf Holdings, Inc. Relocates Curaleaf Phoenix Airport Dispensary to 4415 East Monroe Street	Feb. 20	CI
Curaleaf Holdings, Inc. Celebrates Launch of Adult Use Sales at Hudson Valley, NY Dispensary	Jan. 26	CI
Curaleaf Expands Zero Proof? Brand Portfolio with Launch of Stir Fast-Acting THC Beverage Mix	Jan. 08	CI

Chart Curaleaf Holdings, Inc.

Duration

Period

More charts

Company Profile

Curaleaf Holdings, Inc. is an international provider of consumer products in cannabis. The Company and its brands, including Curaleaf, Select, and Grassroots provide service, product selection and accessibility across the medical and adult-use markets. It operates in approximately 17 states and owns and operates 147 dispensaries and 21 cultivation sites with a focus on states, including Arizona, Florida, Illinois, Massachusetts, New Jersey, New York and Pennsylvania. Curaleaf International is an integrated cannabis company in Europe with a supply and distribution network throughout the European market. It also offers Can4Med, a pharmaceutical wholesaler specializing in cannabinoid medications in Poland. Curaleaf is the national retail dispensary brand in the United States and a mainstream cannabis brand available in multiple states and product formats: vape oils and concentrates, flower, pre rolls and flower pod, topical lotions, capsules and tinctures, mints and lozenges and edibles.

Sector

Pharmaceuticals

Calendar

2024-05-09 - Q1 2024 Earnings Release

More about the company